High-Volume Scanners

PRODUCTS

  • The Challenge: Building Scalable Viral Vector Programs

    Cell and gene therapies offer unprecedented hope for previously untreatable diseases. At the heart of many of these advanced therapies, including both gene therapies and gene-modified cell therapies, are viral vectors, particularly Adeno-Associated Vectors (AAV) and Lentiviral Vectors (LVV), which serve as crucial gene-delivery vehicles.

  • Ascend is the partner for AAV vector design, manufacturability, scale-up and quality assurance. From early pre-clinical phases into the clinic and out on the market, we understand that consistent product quality is not negotiable and work to get it right early on. Our team is always thinking about the scalability of a product to ensure it can have the greatest impact on the patients that need it.

  • Modern clinical trials require modern technology. Leverage the flexibility and speed of the cloud with TrialKit electronic data capture(EDC).

  • Discover how a collaborative approach to medical writing ensures the highest standards of excellence and precision in every document produced.

  • Drive your program forward with an experienced partner ready to execute early-phase clinical research with exceptional speed and scientific rigor.

WHITE PAPERS AND CASE STUDIES

NEWS